Mereo BioPharma Group

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.

About MREO

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).

CEO

Denise Vera Scots-Knight

CEODenise Vera Scots-Knight

Employees

Employees39

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

2015

Founded2015

Employees

Employees39

MREO Key Statistics

Market cap

39.75M

Market cap39.75M

Price-Earnings ratio

-1.43

Price-Earnings ratio-1.43

Dividend yield

—

Dividend yield—

Average volume

1.19M

Average volume1.19M

High today

$0.2722

High today$0.2722

Low today

$0.24

Low today$0.24

Open price

$0.272

Open price$0.272

Volume

1.34M

Volume1.34M

52 Week high

$2.37

52 Week high$2.37

52 Week low

$0.20

52 Week low$0.20

Analyst ratings

71%

of 7 ratings

Buy

71.4%

Hold

14.3%

Sell

14.3%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.